The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1080
June 12, 2000
View Complete Issue         Table of Contents 2019 
Ciclopirox (Penlac) Nail Lacquer for Onychomycosis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ciclopirox (Penlac) Nail Lacquer for Onychomycosis
June 12, 2000 (Issue: 1080)
Ciclopirox nail lacquer (Penlac - Dermik) has been approved by the FDA for treatment of mild-to-moderate onychomycosis due to Trichophyton rubrum, without involvement of the lunula. The drug has been available for many years as a lotion and cream...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Ciclopirox (Penlac) Nail Lacquer for Onychomycosis
Article code: 1080b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.